期刊文献+
共找到1篇文章
< 1 >
每页显示 20 50 100
Orotic Acid, More Than Just an Intermediate of Pyrimidine de novo Synthesis 被引量:4
1
作者 Monika L?ffler Elizabeth A.Carrey Elke Zameitat 《Journal of Genetics and Genomics》 SCIE CAS CSCD 2015年第5期207-219,共13页
It is timely to consider the many facets of the small molecule orotic acid (OA), which is well-known as an essential intermediate of pyrimidine de novo synthesis. In addition, it can be taken up by erythrocytes and ... It is timely to consider the many facets of the small molecule orotic acid (OA), which is well-known as an essential intermediate of pyrimidine de novo synthesis. In addition, it can be taken up by erythrocytes and hepatocytes for conversion into uridine and for use in the pyrimidine recycling pathway. We discuss the link between dietary orotate and fatty liver in rats, and the potential for the alleviation of neonatal hyperbilirubinaemia. We address the development of orotate derivatives for application as anti-pyrimidine drugs, and of com- plexes with metal ions and organic cations to assist therapies of metabolic syndromes. Recent genetic data link human Miller syndrome to defects in the dihydroorotate dehydrogenase (DHODH) gene, hence to depleted orotate production. Another defect in pyrimidine biosynthesis, the orotic aciduria arising in humans and cattle with a deficiency of UMP synthase (UMPS), has different symptoms. More recent work leads us to conclude that OA may have a role in regulating gene transcription. 展开更多
关键词 orotic acid PYRIMIDINES orotic aciduria Miller syndrome Gene defects
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部